Jeong Young-Il, Lee Hwa-Young, Lee Shinyoung, Jeong Ga Yeong, Kim Seo Hyun, Kim Seungyun, Seo Seung-Hee, Shin Na-Ri
Korea Disease Control and Prevention Agency, Cheongju, Korea.
Infect Chemother. 2025 Jun;57(2):203-214. doi: 10.3947/ic.2025.0028. Epub 2025 May 22.
Antimicrobial resistance (AMR) is recognized as one of the top ten global public health threats. Since the coronavirus disease 2019 pandemic, there has been a notable increase in global concern regarding AMR, leading to a strong call for a government-led response to address this issue. Since 2016, the Korean government has established and implemented a robust social foundation for managing AMR. This foundation encompasses several elements: enhancing the medical environment for infection prevention, providing support for the antimicrobial stewardship program in healthcare organizations, strengthening cooperation among multidisciplinary policy ministries, requiring veterinarians to prescribe antimicrobials in non-human fields, and enhancing food safety management in livestock and aquatic products. However, as the threat of AMR has intensified during the ongoing pandemic, the necessity for implementing a National Action Plan becomes even more critical. Therefore, the Third National Action Plan 2026-2030 is crucial to take into account several critical factors: raising awareness of AMR, strengthening of antimicrobial stewardship, halting the spread of antimicrobial-resistant bacteria, strengthening surveillance of antimicrobial use and AMR rates, strengthening internal and external collaborative efforts to combat AMR, and the final factor to consider is to enhance further antimicrobial development and diagnostic technologies to better manage and prevent AMR.
抗菌药物耐药性(AMR)被公认为全球十大公共卫生威胁之一。自2019年冠状病毒病大流行以来,全球对抗菌药物耐药性的关注显著增加,强烈呼吁政府牵头应对这一问题。自2016年以来,韩国政府已建立并实施了一个强大的社会基础来管理抗菌药物耐药性。这个基础包括几个要素:改善感染预防的医疗环境,为医疗机构的抗菌药物管理计划提供支持,加强多学科政策部门之间的合作,要求兽医在非人类领域开具抗菌药物,以及加强对牲畜和水产品的食品安全管理。然而,由于在当前大流行期间抗菌药物耐药性的威胁加剧,实施国家行动计划的必要性变得更加关键。因此,《2026 - 2030年第三次国家行动计划》考虑几个关键因素至关重要:提高对抗菌药物耐药性的认识,加强抗菌药物管理,遏制抗菌药物耐药菌的传播,加强对抗菌药物使用和抗菌药物耐药率的监测,加强国内外抗击抗菌药物耐药性的协作努力,最后一个要考虑的因素是进一步加强抗菌药物研发和诊断技术,以更好地管理和预防抗菌药物耐药性。